Results 211 to 220 of about 686,182 (220)

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

Medicinal Research Reviews, 2008
Stephan W Morris
exaly  

Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)

European Journal of Medicinal Chemistry, 2018
Xiaobao Yang, Jian Jin, Jing Liu
exaly  

Anaplastic lymphoma kinase: Role in cancer and therapy perspective

Cancer Biology and Therapy, 2015
Mutian Zhang, Zhihong Zhao, Vivek Verma
exaly  

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Blood, 2010
Wolfram Klapper, Birgit Burkhardt, Karen Pulford   +2 more
exaly  

ANAPLASTIC LYMPHOMA KINASE IN KIDNEY CANCER

2012
HAACK HERBERT, CROSBY KATHERINE ELEANOR, RIMKUNAS VICTORIA MCGUINNESS, SILVER MATTHEW REN   +3 more
openaire   +2 more sources

Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors

Bioorganic and Medicinal Chemistry Letters, 2011
Kazutomo Kinoshita
exaly  

Expression of anaplastic lymphoma kinase in Merkel cell carcinomas

Human Pathology, 2013
exaly  

Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?

Expert Review of Anticancer Therapy, 2013
Paola Stiuso, Federica Zito Marino, Alessandro Morabito   +2 more
exaly  

Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination

2009
CHIARLE ROBERTO, INGHIRAMI GIORGIO, FORNI GUIDO   +2 more
openaire   +5 more sources

Anaplastic lymphoma kinase (ALK)

2016
openaire   +1 more source